Lv3
300 积分 2023-10-27 加入
Exagamglogene Autotemcel for Severe Sickle Cell Disease
6天前
已关闭
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: An Overview
9天前
已完结
Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
9天前
已完结
Immunobiology and treatment of cutaneous T-cell lymphoma
9天前
已完结
Recent advances on cutaneous lymphoma epidemiology
9天前
已完结
Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China
13天前
已完结
[Chinese expert consensus on iruplinalkib for the treatment of locally advanced or metastatic ALK-positive non-small cell lung cancer (2024 edition)]
13天前
已完结
BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: Efficacy, safety and resistance mechanisms
22天前
已完结
A perspective: the integration of ctDNA into Response Evaluation Criteria in Solid Tumours 1.1 for phase II immunotherapy clinical trials
25天前
已完结
Selinexor in multiple myeloma
1个月前
已完结
皖公网安备34019202002308
